Genomic Valley Biotech Limited Stock

Equities

GVBL6

INE574D01010

Delayed Bombay S.E. 03:16:00 2024-07-11 am EDT 5-day change 1st Jan Change
45.15 INR +5.00% Intraday chart for Genomic Valley Biotech Limited -9.83% +20.59%
Sales 2022 706K 8.45K Sales 2023 27.23M 326K Capitalization 66.44M 796K
Net income 2022 - 0 Net income 2023 6M 71.87K EV / Sales 2022 107 x
Net cash position 2022 26.79K 320.9 Net cash position 2023 413K 4.95K EV / Sales 2023 2.43 x
P/E ratio 2022
-825 x
P/E ratio 2023
10.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Genomic Valley Biotech Limited Announces Appointment of Mrs. Parul Agrawal as an Additional Non-Executive (Non-Independent) Director on the Board with Effect from February 14, 2024 CI
Genomic Valley Biotech Limited Announces Change in Corporate Office Address CI
Genomic Valley Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Genomic Valley Biotech Limited Announces Resignation of Mrs. Jyoti Bansal as Non-Executive (Independent) Director of the Company Effective December 14, 2023 CI
Genomic Valley Biotech Limited Announces Resignation of Parul Agrawal as Non-Executive (Non-Independent) Director and Reconstitution of Committees CI
Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Genomic Valley Biotech Limited Announces Executive Changes CI
Genomic Valley Biotech Limited Approves Shifting of Registered Office CI
Genomic Valley Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Genomic Valley Biotech Limited Appoints Yogesh Agrawal as Chief Financial Officer CI
Genomic Valley Biotech Limited Announces Executive Changes CI
Genomic Valley Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Genomic Valley Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Genomic Valley Biotech CFO Steps Down MT
More news
1 day+5.00%
1 week-9.83%
Current month-26.20%
1 month+18.82%
3 months+28.63%
6 months+7.53%
Current year+20.59%
More quotes
1 week
42.94
Extreme 42.94
50.07
1 month
37.50
Extreme 37.5
64.20
Current year
28.36
Extreme 28.36
64.20
1 year
20.65
Extreme 20.65
64.20
3 years
20.65
Extreme 20.65
64.20
5 years
8.25
Extreme 8.25
64.20
10 years
8.25
Extreme 8.25
64.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 96-03-14
Compliance Officer - 23-03-30
Comptroller/Controller/Auditor - 23-02-09
Members of the board TitleAgeSince
Chief Executive Officer 61 96-03-14
Director/Board Member 53 10-09-28
Director/Board Member 35 23-06-29
More insiders
Date Price Change Volume
24-07-11 45.15 +5.00% 216
24-07-10 43 +0.12% 383
24-07-09 42.95 -4.98% 2,335
24-07-08 45.2 -4.98% 4,541
24-07-05 47.57 -4.99% 2,628

Delayed Quote Bombay S.E., July 11, 2024 at 03:16 am EDT

More quotes